Alzheimer Disease Videos
-
Revolutionize Your Research with the Touch Panel Operant System: An Overview - Video
REQUEST A DEMO to experience the Touch Panel firsthand: http://www.amuzainc.com/contact-us https://www.amuzainc.com/operant-learning-touch-panel/ If you're a researcher in neuroscience or behavioral science, you know how important it is to have reliable data and effective tools to conduct experiments. That's why we're excited to introduce the Touch Panel Operant System - a comprehensive ...
By Amuza Inc.
-
White Matter Microstructure and Alzheimer’s Disease Pathology Insights from Tractography and PET - Video
Amyloid-beta and tau proteins are the main pathological hallmarks of Alzheimer’s disease (AD), which start to deposit in the brain years before any clinical symptoms. Both proteins tend to accumulate in regions that are connected by well-defined anatomical white matter bundles. However, measures of white matter microstructure in relation to AD pathology are not often incorporated in ...
By Imeka
-
Marc Giroux, CEO, Kurve Therapeutics - LSI USA `22 Emerging Medtech Summit - Video
Marc Giroux, CEO of Kurve Therapeutics, was a presenter at the LSI USA ‘22 Emerging Medtech Summit, presenting to an audience of active investors and strategic partners. Kurve brings a breakthrough approach to treat CNS disorders like Mild Cognitive Impairment, Alzheimer's, and Parkinson's. Kurve has completed Phases I, II, IIB and is Phase III ready in MCI. Kurve successfully delivers our ...
-
MD Healthcare Inc. - CNS Nano Dron Drug - Video
#mdhealthcare #microbiome #extracellularvesicle #lactobacillus #endosome Microorganisms produce nano-sized lipid bilayer particles called microbial Extracellular Vesicles or EVs. Some microbial EVs play a key role in regulating human immune function and metabolic homeostasis. MD Healthcare is developing first-in-class smart drugs using Lactobacillus-derived EVs that can be orally ...
-
Project Cribrose - Video
We're recruiting 2000 participants for a non-invasive observational study of Alzheimer's disease. Subjects are needed between 20 and 90 years of age, including healthy subjects and those with Alzheimer's disease, Frontotemporal dementia, Down syndrome, idiopathic dementia, and mild cognitive impairment. Participants are drawn from Southern California only. Visit projectcribrose.com to register ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you